Steris (NYSE:STE) updated its FY 2019 earnings guidance on Monday. The company provided EPS guidance of $4.74-4.84 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.76. The company issued revenue guidance of $2.751-2.751 billion, compared to the consensus revenue estimate of $2.75 billion.
A number of research firms have issued reports on STE. KeyCorp raised their target price on Steris from $120.00 to $132.00 and gave the stock an overweight rating in a research report on Tuesday, November 13th. Zacks Investment Research reissued a buy rating and issued a $132.00 target price on shares of Steris in a research report on Friday, November 16th. Finally, Sidoti raised their target price on Steris from $155.00 to $157.00 and gave the stock a buy rating in a research report on Thursday, December 6th. Five research analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and a consensus price target of $134.20.
Shares of NYSE STE traded up $1.27 during mid-day trading on Monday, hitting $119.86. The company had a trading volume of 772,423 shares, compared to its average volume of 413,651. The stock has a market cap of $10.03 billion, a PE ratio of 28.88 and a beta of 1.04. Steris has a 1 year low of $83.44 and a 1 year high of $121.67. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.01 and a current ratio of 2.63.
In other news, VP John Adam Zangerle sold 1,750 shares of Steris stock in a transaction on Friday, January 11th. The stock was sold at an average price of $110.00, for a total value of $192,500.00. Following the completion of the transaction, the vice president now directly owns 32,546 shares in the company, valued at $3,580,060. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.38% of the stock is currently owned by insiders.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: Cost of Capital Explained
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.